What is Nevro?
Founded in 2006 and headquartered in Redwood City, California, Nevro is a specialized medical device company dedicated to improving the quality of life for patients with chronic pain. The company is recognized for its innovative approach to pain management, leveraging advanced technology to provide effective, non-pharmacological treatment options. By integrating clinical research with engineering excellence, Nevro has established itself as a critical provider in the neurostimulation market, addressing significant unmet needs in the healthcare industry.
How much funding has Nevro raised?
Nevro has raised a total of $921.8M across 10 funding rounds:
Series A
$22M
Series B
$58M
Series C
$48M
Stock Offering
$131M
Debt
$20M
Stock Offering
$118M
Debt
$172.5M
Debt
$189.8M
Stock Offering
$157M
Series A (2008): $22M led by MPM Capital, Aberdare Ventures, Accuitive Medical Ventures, Mayo Clinic, Bay City Capital, and Three Arch Partners
Series B (2011): $58M supported by MPM Capital, Aberdare Ventures, Accuitive Medical Ventures, Mayo Clinic, Johnson & Johnson Development Corporation, Three Arch Partners, and Bay City Capital
Series C (2013): $48M featuring MPM Capital, Accuitive Medical Ventures, Covidien Ventures, Johnson & Johnson Development Corporation, Novo Ventures, New Enterprise Associates, Bay City Capital, Mayo Clinic, and Three Arch Partners
Stock Issuance/Offering (2014): $131M backed by Undisclosed
Debt (2014): $20M with participation from CRG
Stock Issuance/Offering (2015): $118M led by Undisclosed
Debt (2016): $172.5M supported by Undisclosed
Debt (2020): $189.8M featuring Undisclosed
Stock Issuance/Offering (2020): $157M backed by Undisclosed
Key Investors in Nevro
MPM Capital
MPM BioImpact manages early-stage venture funds, private/public impact funds and a public equities fund. We convert science into therapeutics to reach the patients that need them most.
Aberdare Ventures
Aberdare Ventures is a leading venture capital firm that specializes in investing in transformational companies aimed at enhancing healthcare efficiency and reducing costs.
Accuitive Medical Ventures
Accuitive Medical Ventures is a market-driven firm looking for revolutionary medical device technology investment opportunities, often collaborating with The Innovation Factory.
What's next for Nevro?
Following its most recent major strategic investment, Nevro is well-positioned to accelerate its product development pipeline and expand its commercial footprint. The company's focus remains on deepening its clinical evidence base and enhancing its technological offerings to maintain its competitive edge. As the firm moves beyond its initial scaling phases, the focus will likely shift toward broader market penetration and the optimization of its therapeutic delivery systems, ensuring that its solutions remain at the forefront of pain management innovation.
See full Nevro company page
